Interesting facts
Interesting Facts about Methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate
Methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate is a fascinating compound that finds its relevance in various fields, particularly in medicinal chemistry. Here are some noteworthy points about this intriguing molecule:
- Pharmaceutical Applications: The compound is known for its potential use in drug development, particularly in the treatment of conditions like inflammation and cancer. Researchers are continually exploring its bioactive properties.
- Structure-Activity Relationship: The unique structure, featuring the benzimidazole core, contributes to its biological activity. Many drugs are designed around similar frameworks, highlighting the importance of this moiety in pharmacology.
- Material Science: Beyond medicinal uses, compounds like this one are studied in material science for their potential applications in organic electronics and photonic devices.
- Research Opportunities: The compound serves as a benzimidazole derivative, opening up avenues for further modifications and synthesis of new derivatives aimed at enhancing therapeutic efficacy and reducing side effects.
- Green Chemistry: Interest in the synthesis of such compounds is growing in the context of green chemistry. Sustainable methods are being sought to create these compounds with minimal environmental impact.
Research into methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate is ongoing, inspiring scientists to unveil deeper connections between its structure and therapeutic potential. As the field advances, this compound could play a vital role in future medicinal applications.
Synonyms
mebendazole
31431-39-7
Vermox
Pantelmin
Telmin
Ovitelmin
Mebenvet
Vermicidin
Vermirax
Mebenoazole
Mebutar
MBDZ
Bantenol
Besantin
Verpanyl
Lomper
Noverme
Mebendazol
Mebendazolum
Methyl (5-benzoyl-1H-benzo[d]imidazol-2-yl)carbamate
Versid
Emverm
Mebex
5-Benzoyl-2-benzimidazolecarbamic acid methyl ester
Methyl 5-benzoyl-2-benzimidazolecarbamate
methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate
Zhihuanqing
Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester
R 17,635
Methyl 5-benzoyl-2-benzimidazolylcarbamate
MFCD00057872
CCRIS 4479
R 17635
Mebendazol [INN-Spanish]
Mebendazolum [INN-Latin]
Methyl 5-benzoyl benzimidazole-2-carbamate
(5-Benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester
NSC 184849
methyl N-(6-benzoyl-1H-1,3-benzodiazol-2-yl)carbamate
HSDB 3232
methyl (5-benzoyl-1H-benzimidazol-2-yl)carbamate
Methyl N-(5-benzoyl-1H-benzimidazol-2-yl)carbamate
EINECS 250-635-4
NSC-184849
UNII-81G6I5V05I
CHEBI:6704
DTXSID4040682
N-2 (5-Benzoyl-benzimidazole) carbamate de methyle
2-Benzimidazolecarbamic acid, 5-benzoyl-, methyl ester
N-(Benzoyl-5, benzimidazolyl)-2, carbamate de methyle
81G6I5V05I
NSC184849
Sufil
CHEMBL685
R-17635
DTXCID2020682
Carbamic acid, N-(5-benzoylbenzimidazol-2-yl)-, methyl ester
Methyl 6-benzoyl-1H-benzimidazol-2-ylcarbamate
5-Benzoyl-2-benzimidazolecarbamic acid, methyl ester
MMV003152
Mebendazole [USAN:USP:INN:BAN:JAN]
methyl [5-(phenylcarbonyl)-1H-benzimidazol-2-yl]carbamate
NCGC00016806-01
(5-Benzoyl-1H-benzimidazol-2-yl)carbamic acid methyl ester
CAS-31431-39-7
Equivurm Plus
Mebendazol (INN-Spanish)
Mebendazolum (INN-Latin)
MEBENDAZOLE (MART.)
MEBENDAZOLE [MART.]
MEBENDAZOLE (USP-RS)
MEBENDAZOLE [USP-RS]
C16H13N3O3
Vermox (TN)
MEBENDAZOLE (EP MONOGRAPH)
MEBENDAZOLE (USP IMPURITY)
MEBENDAZOLE [EP MONOGRAPH]
MEBENDAZOLE [USP IMPURITY]
MEBENDAZOLE (USP MONOGRAPH)
MEBENDAZOLE [USP MONOGRAPH]
Mebendazole (USAN:USP:INN:BAN:JAN)
SMR000036734
SR-01000003109
Methyl N-(5-benzoyl-2-benzimidazolyl)carbamate
mebendazolo
Mebatreat
Mebendazole (JAN/USP/INN)
Equivurmp Plus
Equivrm Plus
Telmintic Powder
N-2 (5-Benzoyl-benzimidazole) carbamate de methyle [French]
Mebendazole,(S)
N-(Benzoyl-5, benzimidazolyl)-2, carbamate de methyle [French]
V95
Prestwick_310
Telmin Equine Wormer
Mebendazole; 4030
Telmin Syringe Formula
Mebendazole (Standard)
Spectrum_001298
CPD000036734
Prestwick0_000217
Prestwick1_000217
Prestwick2_000217
Prestwick3_000217
Spectrum2_001401
Spectrum3_001439
Spectrum4_000416
Spectrum5_001381
MEBENDAZOLE [INN]
MEBENDAZOLE [JAN]
MEBENDAZOLE [HSDB]
MEBENDAZOLE [USAN]
Probes1_000013
Probes2_000149
MEBENDAZOLE [VANDF]
Cambridge id 5250893
Methyl [5-(Benzoyl)benzimidazol-2-yl]carbamate
TimTec1_000869
Oprea1_278237
Oprea1_768530
SCHEMBL15860
BSPBio_000233
BSPBio_003178
CBDivE_010559
KBioGR_000712
KBioSS_001778
MEBENDAZOLE [WHO-DD]
MEBENDAZOLE [WHO-IP]
MLS000028491
MLS006011879
BIDD:GT0087
DivK1c_000751
MEBENDAZOLUM [WHO-IP]
SPECTRUM1501110
SPBio_001442
SPBio_002154
BPBio1_000257
MEBENDAZOLE [GREEN BOOK]
GTPL13427
HMS502F13
KBio1_000751
KBio2_001778
KBio2_004346
KBio2_006914
KBio3_002398
MEBENDAZOLE [ORANGE BOOK]
MSK5546
P02CA01
Mebendazole for system suitability
NINDS_000751
2-Benzimidazolecarbamic acid, 5-benzoyl-, methyl ester (8CI)
HMS1536H11
HMS1568L15
HMS1921F03
HMS2090B03
HMS2092B15
HMS2095L15
HMS3259B11
HMS3604N11
HMS3712L15
Pharmakon1600-01501110
Tox21_110620
BBL008298
BDBM50180753
CCG-39628
HY-17595R
NSC757838
s4610
STK093862
AKOS000539066
AKOS015896232
Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester (9CI)
Tox21_110620_1
CS-3974
DB00643
FM25020
NC00639
NSC-757838
IDI1_000751
NCGC00016806-02
NCGC00016806-03
NCGC00016806-04
NCGC00016806-05
NCGC00016806-06
NCGC00016806-07
NCGC00016806-08
NCGC00016806-09
NCGC00016806-10
NCGC00016806-12
NCGC00016806-13
NCGC00021698-03
NCGC00021698-04
NCGC00021698-05
NCGC00021698-06
NCGC00021698-07
AC-12064
AS-12272
DA-65310
HY-17595
SY051142
SBI-0051641.P002
AB00052203
M2273
NS00008616
EN300-50844
D00368
D70118
AB00052203-09
AB00052203_10
Mebendazole, VETRANAL(TM), analytical standard
AG-205/04588045
Mebendazole, analytical standard, >=98% (HPLC)
Q422194
methyl 5-benzoyl-1H-benzo[d]imidazol-2-ylcarbamate
SR-01000003109-2
SR-01000003109-3
BRD-K77987382-001-01-7
BRD-K77987382-001-06-6
BRD-K77987382-001-08-2
BRD-K77987382-001-13-2
Methyl (6-benzoyl-1H-benzo[d]imidazol-2-yl)carbamate
SR-01000003109-10
Z234895185
Mebendazole, European Pharmacopoeia (EP) Reference Standard
Mebendazole, United States Pharmacopeia (USP) Reference Standard
Mebendazole for system suitability, European Pharmacopoeia (EP) Reference Standard
250-635-4
N-(6-Benzoyl-1H-benzimidazol-2-yl)carbamic acid methyl ester;5-Benzoyl-2-benzimidazolecarbamic acid methyl ester;Bantenol
Solubility of Methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate
The solubility of methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate (C9H9N3O2) is a critical factor to consider for its potential applications and interactions in various environments. Understanding its solubility characteristics can greatly influence its behavior in chemical processes.
Key Points on Solubility:
In summary, understanding the solubility of methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate is essential for predicting its reactivity, bioavailability, and overall performance in various chemical and biological systems. As a general rule, compounds with greater polarity tend to be more soluble in polar solvents.